HIV-1 Drug-Resistant Minority Variants: Sweating the Small Stuff

被引：7
|
作者：
Li, Jonathan Z. [1 ]
机构：
[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Infect Dis, Boston, MA 02115 USA
来源：
JOURNAL OF INFECTIOUS DISEASES | 2014年 / 209卷 / 05期
关键词：
HIV; minority variants; virologic failure; SINGLE-DOSE NEVIRAPINE; REVERSE-TRANSCRIPTASE; IN-VIVO; INFECTED PATIENTS; SUBTYPE-C; MUTATIONS; THERAPY; FREQUENCY; FAILURE; NAIVE;
D O I：
10.1093/infdis/jit656
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：639 / 641
页数：3
相关论文
共 50 条
  • [1] Primary HIV-1 Drug-Resistant Minority Variants
    Chimukangara, Benjamin
    Samuel, Reshmi
    Naidoo, Kogieleum
    de Oliveira, Tulio
    AIDS REVIEWS, 2017, 19 (02) : 89 - 96
  • [2] Origin of Minority Drug-Resistant HIV-1 Variants in Primary HIV-1 Infection
    Metzner, Karin J.
    Scherrer, Alexandra U.
    Preiswerk, Benjamin
    Joos, Beda
    von Wyl, Viktor
    Leemann, Christine
    Rieder, Philip
    Braun, Dominique
    Grube, Christina
    Kuster, Herbert
    Boeni, Juerg
    Yerly, Sabine
    Klimkait, Thomas
    Aubert, Vincent
    Furrer, Hansjakob
    Battegay, Manuel
    Vernazza, Pietro L.
    Cavassini, Matthias
    Calmy, Alexandra
    Bernasconi, Enos
    Weber, Rainer
    Guenthard, Huldrych F.
    JOURNAL OF INFECTIOUS DISEASES, 2013, 208 (07): : 1102 - 1112
  • [3] The Role of HIV-1 Drug-Resistant Minority Variants in Treatment Failure
    Stella-Ascariz, Natalia
    Ramon Arribas, Jose
    Paredes, Roger
    Li, Jonathan Z.
    JOURNAL OF INFECTIOUS DISEASES, 2017, 216 : S847 - S850
  • [4] Minority Variants of Drug-Resistant HIV
    Gianella, Sara
    Richman, Douglas D.
    JOURNAL OF INFECTIOUS DISEASES, 2010, 202 (05): : 657 - 666
  • [5] Source of HIV-1 drug-resistant minority variants in people who are recently infected
    Mbisa, J.
    Kirwan, P.
    Bibby, D.
    Brown, A.
    Myers, R.
    Murphy, G.
    Ledesma, J.
    Gill, O. N.
    Delpech, V.
    Asboe, D.
    Pozniak, A.
    Sabin, C.
    Dunn, D.
    Tostevin, A.
    Kirk, S.
    HIV MEDICINE, 2017, 18 : 6 - 6
  • [6] A bibliometric analysis of HIV-1 drug-resistant minority variants from 1999 to 2024
    Chang Yan
    Fengting Yu
    Mengying Li
    Xiaojie Yang
    Rui Sun
    Xuelei Liang
    Xiaojie Lao
    Hanxi Zhang
    Wenhao Lv
    Ying Hu
    Yuan Lai
    Yi Ding
    Fujie Zhang
    AIDS Research and Therapy, 22 (1)
  • [7] Infrequent transmission of HIV-1 drug-resistant variants
    Yerly, S
    Jost, S
    Telenti, A
    Flepp, M
    Kaiser, L
    Chave, JP
    Vernazza, P
    Battegay, M
    Furrer, H
    Chanzy, B
    Burgisser, P
    Rickenbach, M
    Gebhardt, M
    Bernard, MC
    Perneger, T
    Hirschel, B
    Perrin, L
    ANTIVIRAL THERAPY, 2004, 9 (03) : 375 - 384
  • [8] When Do Minority Drug-Resistant HIV-1 Variants Have a Major Clinical Impact?
    Heneine, Walid
    JOURNAL OF INFECTIOUS DISEASES, 2010, 201 (05): : 647 - 649
  • [9] Detection of drug-resistant minority variants of HIV-1 during virologic failure of indinavir, lamivudine, and zidovudine
    Dykes, C
    Najjar, J
    Bosch, RJ
    Wantman, M
    Furtado, M
    Hart, S
    Hammer, SM
    Demeter, LM
    JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (06): : 1091 - 1096
  • [10] Transmitted minority drug-resistant HIV variants: A new epidemic?
    Deeks, Steven G.
    PLOS MEDICINE, 2008, 5 (07) : 1014 - 1016
12345